| Literature DB >> 29203637 |
Y Liu1, H Zhu1, H Hong1, W Wang1, F Liu2.
Abstract
OBJECTIVES: Recently, high failure rates of metal-on-metal (MOM) hip implants have raised concerns of cobalt toxicity. Adverse reactions occur to cobalt nanoparticles (CoNPs) and cobalt ions (Co2+) during wear of MOM hip implants, but the toxic mechanism is not clear.Entities:
Keywords: Cobalt cytotoxicity; Cobalt ions; Cobalt nanoparticles; Protective effects; Zinc
Year: 2017 PMID: 29203637 PMCID: PMC5935811 DOI: 10.1302/2046-3758.612.BJR-2016-0137.R2
Source DB: PubMed Journal: Bone Joint Res ISSN: 2046-3758 Impact factor: 5.853

Viability of Balb/3T3 cells exposed to cobalt nanoparticles (CoNPs) and cobalt ions (Co2+) for a) four, b) 24, c) and 48 hours, as determined by Cell-Counting Kit 8 assay. All data were expressed as means ± standard deviation of three independent experiments performed in triplicate. *p < 0.05 compared with the control group.
Fig. 2Protective effect of zinc ions (Zn2+) pretreatment against cytotoxicity induced by cobalt nanoparticles (CoNPs) and cobalt ions (Co2+) was measured in Balb/3T3cells. The cells were pretreated with 50 μM Zn2+ for four hours and subsequently exposed to 100 μM CoNPs and 500 μM Co2+for 24 hours. Cells cultured with serum-free medium served as control group. Cell viability was measured by Cell-Counting Kit 8 assay. The values were presented as means ± standard deviation from three independent experiments. *p < 0.05 compared with the control group. †p < 0.05 compared with the relevant treatment group.
Fig. 3Relative percentage change in the production of reactive oxygen species (ROS) was measured on cobalt ions (Co2+), cobalt nanoparticles (CoNPs) and zinc ions (Zn2+) pretreated groups. Each value represents the mean ± standard deviation of three independent experiments, performed in triple. *p < 0.05 compared with control group. †p < 0.05 compared with Co2+ treated group. ‡p < 0.05 compared with the CoNPs treated group.

Effect of zinc ions (Zn2+) pretreatment on a) tumour necrosis factor-α (TNF-α), b) interleukin-6 (IL-6) and c) interleukin-1β (IL-1β) levels in Balb/3T3 cells treated with cobalt nanoparticles (CoNPs) and cobalt ions (Co2+). Balb/3T3 cells were pretreated with 50 μM Zn2+ for four hours, followed by treatment with 100 μM Co2+ and 50 μM CoNPs for 24 hours. Data were expressed as the mean ± standard deviation. *p < 0.05 compared with the control group. †p < 0.05 compared with the Co2+ treated group. ‡p < 0.05 compared with the CoNPs treated group.